Gram-negative bacterial infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years old. 2.Diagnosed with severe infections (such as sepsis, pneumonia, intra-abdominal infections) caused by Gram-negative drug-resistant bacteria. 3.Receiving treatment with colistin sulfate (including loading and maintenance doses), with an expected treatment duration of >= 48 hours. 4.ICU inpatients with stable conditions, capable of undergoing blood sample collection. 5.Consent to participate in the study and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Allergic to any component of colistin sulfate for injection. 2.Pregnant women, breastfeeding women, or patients planning to become pregnant in the near future. 3.Inability to collect sufficient blood samples due to medical conditions or technical reasons. 4.Patients deemed unsuitable for participation in the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma concentration;Serum Biochemistry;Coagulation Function;Arterial Blood Gas Analysis;Electrocardiogram;Chest Computed Tomography; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital signs;Complete Blood Count; | — |
Countries
China
Contacts
Chinese PLA General Hospital